4//SEC Filing
Magnani John L. 4
Accession 0001209191-18-055586
CIK 0001253689other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 5:36 PM ET
Size
9.8 KB
Accession
0001209191-18-055586
Insider Transaction Report
Form 4
Magnani John L.
DirectorVP of Research, CSO
Transactions
- Sale
Common Stock
2018-10-16$14.01/sh−14,200$198,942→ 86,593 total - Sale
Common Stock
2018-10-17$14.00/sh−7,273$101,822→ 79,320 total - Sale
Common Stock
2018-10-18$14.02/sh−3,527$49,449→ 75,793 total
Holdings
- 4,845(indirect: By GlycoTech Corporation)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on September 21, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F4]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.
Documents
Issuer
GLYCOMIMETICS INC
CIK 0001253689
Entity typeother
Related Parties
1- filerCIK 0001589713
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 5:36 PM ET
- Size
- 9.8 KB